[
1. UNAIDS. Global AIDS Update 2016. Geneva: United Nations. 2016. Available from: https://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016
]Search in Google Scholar
[
2. Thio CL, Seaberg EC, Skolasky RJ, Phair J, Visscher B, Muñoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (London, England). 2002 Dec;360(9349):1921–6.10.1016/S0140-6736(02)11913-1
]Search in Google Scholar
[
3. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005 Mar;19(6):593–601.10.1097/01.aids.0000163936.99401.fe15802978
]Search in Google Scholar
[
4. Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JMA, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS. 2004 May;18(8):1169–77.10.1097/00002030-200405210-0001015166532
]Search in Google Scholar
[
5. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010 Jan;85(1):303–15.10.1016/j.antiviral.2009.10.02119887087
]Search in Google Scholar
[
6. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001; 33(4):562-9.10.1086/32190911462196
]Search in Google Scholar
[
7. McGovern BH, Golan Y, Lopez M, et al. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. Clin Infect Dis. 2007; 44(3):431-7.10.1086/50958017205454
]Search in Google Scholar
[
8. Vivithanaporn P, Maingat F, Lin L-T, Na H, Richardson CD, Agrawal B, et al. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity. PLoS One. 2010 Sep;5(9):e12856.10.1371/journal.pone.0012856294347020877724
]Search in Google Scholar
[
9. Reynolds SJ, Risbud AR, Shepherd ME, Rompalo AM, Ghate M V, Godbole S V, et al. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex Transm Infect. 2006 Apr;82(2):121–6.10.1136/sti.2005.015040256468216581736
]Search in Google Scholar
[
10. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3–17.10.1136/sti.75.1.3175816810448335
]Search in Google Scholar
[
11. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004 Oct;18(15):2075–9.10.1097/00002030-200410210-00012676362015577629
]Search in Google Scholar
[
12. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2007 May;44(9):1222–8.10.1086/51342717407043
]Search in Google Scholar
[
13. Monitoring the AIDS Pandemic (MAP) Network. The status and trends of the HIV/AIDS Epidemics in the World. Geneva: 1998.
]Search in Google Scholar
[
14. Raviglione MC, Snider DEJ, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995 Jan;273(3):220–6.10.1001/jama.273.3.220
]Search in Google Scholar
[
15. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AB, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir immune Defic Syndr Hum retrovirology Off Publ Int Retrovirology Assoc. 1995 Apr;8(4):386–91.10.1097/00042560-199504000-00010
]Search in Google Scholar
[
16. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS; 24:1243-1250.10.1097/QAD.0b013e3283354a7b19996937
]Search in Google Scholar
[
17. Committee TUKCHIVC (CHIC) SS. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. Eur J Neurol. 2011;18(3):527–34.10.1111/j.1468-1331.2010.03291.x21159073
]Search in Google Scholar
[
18. Dai L, Mahajan SD, Guo C, Zhang T, Wang W, Li T, et al. Spectrum of central nervous system disorders in hospitalized HIV/AIDS patients (2009-2011) at a major HIV/AIDS referral center in Beijing, China. J Neurol Sci. 2014 Jul;342(1–2):88–92.10.1016/j.jns.2014.04.03124836573
]Search in Google Scholar
[
19. Institute of Medicine (US) Committee on Social Security HIV DC. HIV and Disability: Updating the Social Security Listings. Washington (DC): National Academies Press; 2010. 1–200 p.
]Search in Google Scholar
[
20. Brew BJ. (2016) Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment? AIDS; 30:2379–238010.1097/QAD.000000000000122527603161
]Search in Google Scholar
[
21. Cameron CE, Brouwer NL, Tisch LM, Kuroiwa JMY. Defining the interaction of the Treponema pallidum adhesin Tp0751 with laminin. Infect Immun. 2005 Nov;73(11):7485–94.10.1128/IAI.73.11.7485-7494.2005127386216239550
]Search in Google Scholar
[
22. Furtado GC, Slowik M, Kleinman HK, Joiner KA. Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells. Infect Immun. 1992 Jun;60(6):2337–42.10.1128/iai.60.6.2337-2342.19922571631534073
]Search in Google Scholar
[
23. Toms C, Stapledon R, Coulter C, Douglas P. Tuberculosis notifications in Australia, 2014. Commun Dis Intell Q Rep. 2017 Sep;41(3):E247—E263.
]Search in Google Scholar
